Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the type 2 diabetes market grown over the years?

The type 2 diabetes market has grown considerably and is forecasted to increase from $48.14 billion in 2024 to $51.96 billion in 2025, at a CAGR of 7.9%. Contributing factors include lifestyle and dietary changes, an aging population, pharmaceutical innovations, and public health initiatives.

What Is the forecasted market size and growth rate for the type 2 diabetes market?

The type 2 diabetes market is expected to witness strong growth, reaching $72.22 billion in 2029 at a CAGR of 8.6%. Growth factors include the global diabetes epidemic, the rise of personalized medicine, technological innovations, and shifts in healthcare policies. Major trends include digital health adoption, AI and ML applications, preventive care, and metabolic surgery.

Get your type 2 diabetes market report here!

https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

What are the major factors driving growth in the type 2 diabetes market?

The projection of the type 2 diabetes market is set to expand, primarily driven by the escalating rates of obesity and heart disease. Obesity, a health condition marked by excessive body fat levels, and heart disease, a term encompassing a variety of heart and blood vessels-related conditions, are becoming prevalent. Overweight individuals are at higher risk of insulin resistance, which can cause elevated blood sugar levels, thus triggering the development of type 2 diabetes. Conversely, high blood sugar levels can inflict damage upon blood vessels and nerves controlling the heart and blood vessels, leading to heart ailments. For instance, in March 2024, the World Health Organization (WHO), a Swiss-based intergovernmental entity, revealed that about one-eighth of the global population were grappling with obesity. This comprised 2.5 billion overweight adults who are 18 years and above, with 890 million of them suffering from obesity. Among these adults, 43% were overweight, and 16% were categorized as obese. Moreover, the count of overweight children aged under 5 hit 37 million. Hence, the rising incidences of obesity and heart disease are stimulating the growth of the type 2 diabetes market.

Type 2 Diabetes Market Driver: Surge in Elderly Population Fuels Type 2 Diabetes Market Expansion

What key areas define the segmentation of the global type 2 diabetes Market?

The type 2 diabetes market covered in this report is segmented –

1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes

2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications

3) By End-User: Children, Adults

Subsegments:

1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide, Semaglutide, Dulaglutide, Exenatide

3) By Thiazolidinediones: Pioglitazone, Rosiglitazone

4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol

5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride, Glipizide, Glyburide

6) By Biguanides: Metformin

7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin

8) By Other Drug Classes: Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp

What are the top market players propelling the growth of the type 2 diabetes industry?

Major companies operating in the type 2 diabetes market are F. Hoffmann-La Roche AG, Merck and Co. Inc., Novartis AG, AstraZeneca PLC, Abbott Laboratories, Sanofi SA, Medtronic PLC, Takeda Pharmaceutical Company, GlaxoSmithKline plc., Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Dexcom Inc., Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Byram Healthcare, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health.

What are the key trends shaping the future of the type 2 diabetes market?

Leading firms immersed in the type 2 diabetes industry are innovating with new products like Mounjaro, aiming to elevate safety and efficacy for patients with diabetes. The objective of these trailblazing medications such as Mounjaro is to improve the effectiveness, safety, and manageability of diabetes treatment compared to traditional drugs. The creative evolution in diabetes medication formulation concentrates on enhancing blood glucose management, reducing potential side effects, and tackling other related health issues. To illustrate, in May 2022, the U.S. Food and Drug Administration granted approval to Eli Lilly and Co., a pharmaceutical organization based in the U.S., for their Mounjaro (tripeptide) injection designed to upgrade blood glucose control in adults with type 2 diabetes, in tandem with diet and physical exercise. Tirzepatide positions itself as a fresh, dual-action treatment for type 2 diabetes. Administered weekly through an injection, it impacts two hormones responsible for the regulation of blood sugar levels, namely glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). While GLP-1 amplifies insulin production and reduces glucagon production, GIP enhances insulin production. Therefore, Tirzepatide stands as a hopeful new treatment pathway for individuals with type 2 diabetes, even those who have failed to see benefits from previous treatments.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13050

What regions are dominating the type 2 diabetes market growth?

North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Pet Diabetes Care Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Smart Insulin Pens Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Artificial Intelligence in Diabetes Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: